CIMETIDINE CLEARANCE IN THE OBESE

被引：25

作者：

BAUER, LA

WAREINGTRAN, C

EDWARDS, WAD

RAISYS, V

FERRERI, L

JACK, R

DELLINGER, EP

SIMONOWITZ, D

机构：

[1] UNIV WASHINGTON,SCH MED,DEPT LAB MED,SEATTLE,WA 98195

[2] UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195

来源：

关键词：

D O I：

10.1038/clpt.1985.66

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：425 / 430

页数：6

共 26 条

[1] ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91
[2] ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39
[3] AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS
BAUER, LA
BLOUIN, RA
GRIFFEN, WO
RECORD, KE
BELL, RM
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04): : 519 - 522
[4] INFLUENCE OF WEIGHT ON AMINOGLYCOSIDE PHARMACOKINETICS IN NORMAL WEIGHT AND MORBIDLY OBESE PATIENTS
BAUER, LA
EDWARDS, WAD
DELLINGER, EP
SIMONOWITZ, DA
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (05) : 643 - 647
[5] TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS
BLOUIN, RA
MANN, HJ
GRIFFEN, WO
BAUER, LA
RECORD, KE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) : 508 - 512
[6] VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS
BLOUIN, RA
BAUER, LA
MILLER, DD
RECORD, KE
GRIFFEN, WO
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) : 575 - 580
[7] PHARMACOKINETICS OF CIMETIDINE AFTER SINGLE DOSES AND DURING CONTINUOUS TREATMENT
BODEMAR, G
NORLANDER, B
WALAN, A
[J]. CLINICAL PHARMACOKINETICS, 1981, 6 (04) : 306 - 315
[8] BODEMAR G, 1977, 2ND P INT S HIST H2, P224
[9] PHARMACOLOGICAL EVALUATION OF CIMETIDINE, A NEW HISTAMINE H2-RECEPTOR ANTAGONIST, IN HEALTHY MAN
BURLAND, WL
DUNCAN, WAM
HESSELBO, T
MILLS, JG
SHARPE, PC
HAGGIE, SJ
WYLLIE, JH
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (06) : 481 - 486
[10] DEDRICK RL, 1980, FED PROC, V39, P54